In the case description, we present the immunohistochemistry and pathologic characteristics identifying the tumor as an anaplastic oligodendroglioma, IDH-mutant, 1p/19q codeleted, with ATRX expression isolated within a vast majority of areas that were lower-grade glioma. This evidence concerns the gene ATRX and neoplasm.